Article

NeurologyLive® Friday 5 — December 23, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 23, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Tempering Expectations on High-Clearance Anti-Amyloid Immunotherapies in Alzheimer Disease: Nicolas Villain, MD

The cognitive and behavioral neurology fellow at Pitié-Salpêtrière Hospital in Paris, France, provided background on a study presented at CTAD 2022 assessing the efficacy of prominent, up-and-coming anti-amyloid therapies. [WATCH TIME: 7 minutes]

Tempering Expectations on High-Clearance Anti-Amyloid Immunotherapies in Alzheimer Disease: Nicolas Villain, MD

2: Peer Exchange: Discontinuation of Treatment for Pregnancy in Multiple Sclerosis

In episode 10 of the NeurologyLive® series, "Challenges and Solutions in the Management of Multiple Sclerosis," an expert panel consisting of Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, considers patients with multiple sclerosis who may need to discontinue treatment during pregnancy.

Discontinuation of Treatment for Pregnancy in Multiple Sclerosis

3: NeuroVoices: Miia Kivipelto, MD, PhD, on Using Multidomain Interventions to Prevent Cognitive Decline

In the latest edition of our in-depth Q&A series, the professor of clinical geriatric epidemiology at Karolinska Institutet provided perspective on the FINGERS trial, the first study to show it is possible to prevent cognitive decline using a multidomain lifestyle intervention.

NeuroVoices: Miia Kivipelto, MD, PhD, on Using Multidomain Interventions to Prevent Cognitive Decline

4: NeurologyLive® Year in Review 2022: Most-Read Features

Throughout the course of the year, the NeurologyLive® team and a number of clinician and physician partners put together feature-length, in-depth articles that encapsulate the topics and themes that have driven the conversations in the field of neurology in 2022. As part of NeurologyLive®'s Year in Review, we've compiled the most-read feature-length stories that appeared on the website in 2022.

NeurologyLive® Year in Review 2022: Most-Read Features

5: Institutional Perspectives in Neurology, Chaired by Robert Bermel, MD

Chaired by Robert Bermel, MD, of Cleveland Clinic, the presentations also feature Jeffrey Cohen, MD; Amy Kunchock, MBBS, MMed; and Brandon Moss, MD. [WATCH TIME: 1 hour, 30 minutes]

Institutional Perspectives in Neurology, Chaired by Robert Bermel, MD

—————————————————

Related Videos
Gil Rabinovici, MD
MaryAnn Mays, MD
Henri Ford, MD, MHA
Michael Levy, MD, PhD, is featured in this series.
David A. Hafler, MD, FANA
© 2024 MJH Life Sciences

All rights reserved.